You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
魯泰A(000726.SZ):作價1.42億元轉讓榮昌生物出資額300萬元
格隆匯 03-06 17:30

格隆匯3月6日丨魯泰A(000726.SZ)公佈,公司2010年以子公司魯泰環中製藥全部資產向榮昌股份投資,持股500萬股,佔比5.56%。榮昌股份後經多次增資擴股,截止2019年11月末,公司持股500萬股,佔比2.96%。2019年12月榮昌股份對其全資子公司榮昌生物進行了分拆重組,即將榮昌生物從榮昌股份分拆,且榮昌股份的股東全部平移至榮昌生物持股。分拆後公司持有榮昌股份500萬股,佔比為2.92%。

公司將其原通過榮昌股份間接持有榮昌生物的股權變更為直接持有榮昌生物的股權,公司受讓榮昌生物部分出資額的轉讓價格為21.50萬元,分拆後公司持有榮昌生物491.7393萬元出資額,佔比2.96%,後榮昌生物經增資擴股,公司現持有榮昌生物491.7393萬元出資額,佔比2.69%。

公司擬向CRF Investment Holdings Company Limited、上海檀英投資合夥企業(有限合夥)、國投(上海)科技成果轉化創業投資基金企業(有限合夥)、PAG Growth Holding Ⅳ(HK) Limited、深圳市創新投資集團有限公司、LAV Remegen Limited\蘇州禮瑞\蘇州禮康、Janchor Partners Pan-Asian Master Fund、LBC Sunshine Healthcare Fund L.P.轉讓公司所持有榮昌生物出資額300萬元,協商確定轉讓價款摺合人民幣總計1.4163億元。

公告顯示,榮昌生物成立於2008年7月4日;法定代表人王威東;主營業務包括研發、生產和銷售醫藥產品、診斷試劑產品、以及進行與上述產品及其研發相關的技術服務、技術轉讓、貨物或技術進出口。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account